Form 4: BioCardia CEO Sells Shares

BioCardia, Inc. President and CEO Peter Altman reported a transaction involving the sale of 5,400 shares of common stock.

Summary

• Peter Altman, President and CEO of BioCardia, Inc., sold 5,400 shares of common stock on July 8, 2026.
• The sale was executed at a weighted average price of $0.9645 per share, with individual transactions ranging from $0.92 to $1.05.
• Following this transaction, Altman beneficially owns 361,985 shares of common stock.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a slightly negative sentiment due to the CEO selling shares, which can be perceived as a lack of confidence, despite the sale being a small portion of his holdings.

Negatives

• The CEO sold a portion of his holdings, which could be interpreted negatively by the market.

Future Outlook

No forward-looking statements or guidance were provided in this filing.

Industry Context

StockSavvy.ai notes that insider selling, particularly by a CEO, can sometimes signal a lack of confidence in the company's near-term prospects, although it can also be for personal financial planning reasons.

Stakeholder Impact

• Shareholders may view the CEO's sale of stock with concern, potentially impacting share price.

Key Dates

Recommendation

The filing reports an insider sale by the CEO. While this can be a negative signal, the sale represents a small portion of his holdings and the price range indicates market activity. Without further context on the company's performance or the CEO's reasons for selling, a 'hold' recommendation is prudent, suggesting investors monitor future filings and company performance.

Keywords

BioCardia, BCDA, Form 4, Insider Trading, Stock Sale, Peter Altman, CEO